Form 4 for ZBH Zimmer Biomet
Accepted 2024-02-26 00:00:00 ET · period of report 2024-02-22 · accession 0001062993-24-004448 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-26 | 2024-02-22 | ZBH | Phipps Chad F | SVP, Gen Counsel, Sec | S - Sale+OE | $128.62 | -26.2K | 44.1K | -37% | -$3.36M |
| D | 2024-02-26 | 2024-02-22 | ZBH | Phipps Chad F | SVP, Gen Counsel, Sec | M - OptEx | $91.53 | +26.2K | 70.3K | +59% | +$2.39M |
| D | 2024-02-26 | 2024-02-22 | ZBH | Phipps Chad F | SVP, Gen Counsel, Sec | M - OptEx | $0.00 | -26.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-22 | S | D | 25,546 | $128.61 | 44,755 | D | — | — | (F2) Reflects the weighted average price of 25,546 shares of common stock of Zimmer Biomet Holdings, Inc. sold in multiple transactions on February 22, 2024 with sale prices ranging from $128.03 to $128.99 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuance, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2024-02-22 | M | A | 26,156 | $91.53 | 70,301 | D | — | — | (F1) Includes 474 shares acquired under the Employee Stock Purchase Plan and pursuant to dividend reinvestment through February 1, 2024. |
| 3 | Common | Common Stock | 2024-02-22 | S | D | 610 | $129.08 | 44,145 | D | — | — | (F3) Reflects the weighted average price of 610 shares of common stock of Zimmer Biomet Holdings, Inc. sold in multiple transactions on February 22, 2024 with sale prices ranging from $129.06 to $129.11 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuance, full information regarding the number of shares sold at each separate price. |
| 4 | Derivative | Employee Stock Option (right to buy) | 2024-02-22 | M | D | 26,156 | $0.00 | 0 | D | $91.53 · — to 2024-03-17 | 26,156 Common Stock | (F4) Fully vested. |